84 related articles for article (PubMed ID: 22684654)
1. Effect of losartan on the glomerular protein expression profile of type 2 diabetic KKAy mice.
Fan QL; Yang G; Liu XD; Ma JF; Feng JM; Jiang Y; Wang LN
J Nephrol; 2013; 26(3):517-26. PubMed ID: 22684654
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profile in glomeruli of type-2 diabetic KKAy mice using 2-dimensional differential gel electrophoresis.
Liu X; Yang G; Fan Q; Wang L
Med Sci Monit; 2014 Dec; 20():2705-13. PubMed ID: 25515740
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice.
Zhu X; Zhang C; Fan Q; Liu X; Yang G; Jiang Y; Wang L
Med Sci Monit; 2016 Oct; 22():3902-3909. PubMed ID: 27770539
[TBL] [Abstract][Full Text] [Related]
4. Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
Sasaki M; Uehara S; Ohta H; Taguchi K; Kemi M; Nishikibe M; Matsumoto H
Life Sci; 2004 Jul; 75(7):869-80. PubMed ID: 15183078
[TBL] [Abstract][Full Text] [Related]
5. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes.
Deb DK; Sun T; Wong KE; Zhang Z; Ning G; Zhang Y; Kong J; Shi H; Chang A; Li YC
Kidney Int; 2010 Jun; 77(11):1000-9. PubMed ID: 20182412
[TBL] [Abstract][Full Text] [Related]
6. Automated image analysis of a glomerular injury marker desmin in spontaneously diabetic Torii rats treated with losartan.
Kakimoto T; Okada K; Hirohashi Y; Relator R; Kawai M; Iguchi T; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
J Endocrinol; 2014 Jul; 222(1):43-51. PubMed ID: 24781258
[TBL] [Abstract][Full Text] [Related]
7. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Hagiwara S; Makita Y; Gu L; Tanimoto M; Zhang M; Nakamura S; Kaneko S; Itoh T; Gohda T; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2006 Mar; 21(3):605-15. PubMed ID: 16282336
[TBL] [Abstract][Full Text] [Related]
8. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
9. Low-protein diet supplemented with ketoacids delays the progression of diabetic nephropathy by inhibiting oxidative stress in the KKAy mice model.
Liu D; Wu M; Li L; Gao X; Yang B; Mei S; Fu L; Mei C
Br J Nutr; 2018 Jan; 119(1):22-29. PubMed ID: 29208058
[TBL] [Abstract][Full Text] [Related]
10. [Effect of losartan on expression of Janus kinase 2 and signal transducer and activator of transcription 3 in glomeruli of diabetic rats].
Shi YH; Duan HJ; He N; Wang LH; Liu QJ; Gao F
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Nov; 17(11):662-6. PubMed ID: 16297319
[TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
13. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice.
Reddy MA; Sumanth P; Lanting L; Yuan H; Wang M; Mar D; Alpers CE; Bomsztyk K; Natarajan R
Kidney Int; 2014 Feb; 85(2):362-73. PubMed ID: 24088954
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
15. The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
Qing-Hua G; Ju-Ming L; Chang-Yu P; Zhao-Hui L; Xiao-Man Z; Yi-Ming M
J Diabetes Complications; 2008; 22(6):408-12. PubMed ID: 18413157
[TBL] [Abstract][Full Text] [Related]
16. Enhanced effect of combined treatment with SMP-534 (antifibrotic agent) and losartan in diabetic nephropathy.
Sugaru E; Nakagawa T; Ono-Kishino M; Nagamine J; Tokunaga T; Kitoh M; Hume WE; Nagata R; Taiji M
Am J Nephrol; 2006; 26(1):50-8. PubMed ID: 16508247
[TBL] [Abstract][Full Text] [Related]
17. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes.
Zhang D; Yang H; Kong X; Wang K; Mao X; Yan X; Wang Y; Liu S; Zhang X; Li J; Chen L; Wu J; Wei M; Yang J; Guan Y
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E287-95. PubMed ID: 20959534
[TBL] [Abstract][Full Text] [Related]
18. Losartan in diabetic nephropathy.
Perico N; Ruggenenti P; Remuzzi G
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy.
Manucha W; Carrizo L; Ruete C; Molina H; Vallés P
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):547-55. PubMed ID: 16309579
[TBL] [Abstract][Full Text] [Related]
20. Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy.
Tufescu A; Kanazawa M; Ishida A; Lu H; Sasaki Y; Ootaka T; Sato T; Kohzuki M
J Hypertens; 2008 Feb; 26(2):312-21. PubMed ID: 18192846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
